Smoking cessation and weight gain

Size: px
Start display at page:

Download "Smoking cessation and weight gain"

Transcription

1 Smoking cessation and weight gain David McFadden, MD, MPH Mayo Clinic Nicotine Dependence Center 2012 MFMER slide-1

2 Disclosures I presented lectures for Pfizer-sponsored tobacco treatment seminars in Brazil, Mexico and Chile I received no direct fees, but Mayo Clinic Nicotine Dependence center was reimbursed for my services MFMER slide-2

3 Objectives 1. Understand the relationship of smoking cessation to weight gain 2. Understand the proposed mechanism of weight gain post smoking cessation 3. Understand the impact of weight gain concerns on tobacco use 4. To review the pharmaceutical approach to treating nicotine dependence with weight neutralizing drugs MFMER slide-3

4 Tobacco mortality annual WHO estimates 6 million deaths annually worldwide due to smoking By 2030 estimated 8 million deaths 80% will occur in less developed countries (China and India) Since 1964 smoking prevalence in the USA declined dramatically, BUT it s decline has stalled over the last 6 years MFMER slide-4

5 Obesity problem 1/3 of the American population 2 nd most important cause of preventable mortality in the USA (after smoking) Risk factor for Diabetes, Cardiovascular disease, Obstructive Sleep Apnea, Hypertension, Dyslipidemia 2012 MFMER slide-5

6 Challenges Weight gain is very common after smoking cessation Weight gain concern-barrier to quitting cigarette smoking and obesity are both risk factors for several highly prevalent lifestyle diseases (cardiovascular disease and diabetes) 2012 MFMER slide-6

7 Weight smokers vs. nonsmokers On average smokers weigh 5 kg (10.4 lbs.) less than nonsmokers Smokers gain an average for 4-5 kg. within 6-12 months of quitting 13% of smokers gain >10 kg.(22 lbs.) African American smokers Age <55 Low social-economic status 2012 MFMER slide-7

8 Weight gain with smoking cessation Average gain 7 to 19 lbs within 8 years of quitting Continued smokers gain 4-5 lbs. Most weight gain --within 6 months of quitting; greatest within the first month 10% of smokers may gain up to 30 lbs. (ref. 1) 2012 MFMER slide-8

9 2012 MFMER slide-9

10 2012 MFMER slide-10

11 Weight gain Underweight smokers (BMI 18) or overweight smokers (BMI >29) have the greatest weight gain after quitting smoking Only 25% of former smokers maintain a healthy weight after quitting 2012 MFMER slide-11

12 Trajectories of cigarette smoking as predictor of obesity Heavy/continuous smokers compared with nonsmokers had a significantly lower likelihood of obesity. Also Heavy/continuous smokers had a significantly lower likelihood of being overweight or obese compared with non-daily occasional smokers. (ref. 3) 2012 MFMER slide-12

13 A Paradox the Obese smoker 20% of smokers are obese (BMI>30) Higher ratio of visceral to SQ fat risk of Diabetes and CVD Those who smoke the most cigarettes per day had the highest weight. (ref. 1) 2012 MFMER slide-13

14 Longitudinal change in weight related to smoking cessation EPIC-PANACEA study (European Prospective Investigation into Cancer and Nutrition-Physical Activity, alcohol, cessation of smoking) 300,000 healthy volunteers from 9 European countries followed for 5 years. Anthropometric and smoking habit data obtained (ref. 4) 2012 MFMER slide-14

15 results Smoking cessation resulted in annual weight gain; men (0.44 kg.), women (0.36 kg.) However when smokers who quit at least 1 year before study recruitment were compared with never smokers, there was no difference in annual weight gain Weight gain occurs mainly in the first year after smoking cessation (ref.4) 2012 MFMER slide-15

16 Why does it happen? Why do smokers gain weight after quitting smoking? Physiologic?? Psychologic?? 2012 MFMER slide-16

17 weight gain after smoking cessation Mechanisms are complex and NOT completely understood: two hypothesis 1.physiologic- mechanism due to action of nicotine 2.behavioral --smoking a cigarette -- alternative to eating MFMER slide-17

18 Pathophysiology Body weight is determined by balance of caloric (energy) intake vs. daily energy calorie (energy) expenditure Daily energy expenditure is a combination of resting metabolic rate, physical activity and thermic effects of food MFMER slide-18

19 Nicotine action Nicotine raises resting metabolic rate while suppressing appetite. Nicotine is a sympathomimetic drug similar to other antiobesity drugs. Sympathomimetic drugs increase energy expenditure MFMER slide-19

20 Nicotine action Acts on nicotinic cholinergic brain receptor and autonomic ganglia which results in release of several neurotransmitters Dopamine, norepinephrine, serotonin, acetylcholine, glutamate and GABA 2012 MFMER slide-20

21 2012 MFMER slide-21

22 Nicotine action Increases thermogenesis in adipose tissue by increasing lipolysis and recycling of fatty acids into triglycerides Increases 24 hr. energy expenditure by 10%= 200kcal per 24 hrs. This amount of energy expenditure 10 kg. weight loss in 1 year if steady state metabolism maintained MFMER slide-22

23 Nicotine CNS effects Eating behavior and metabolic rate are regulated by the hypothalamus which integrates signals of satiety and adiposity as well as central motivational and emotional influences. Leptin plays a role in these mechanisms 2012 MFMER slide-23

24 Nicotine CNS action Norepinephrine, dopamine, serotonin and GABA influence other brain chemicals that suppress appetite and increase metabolic rate such as Pro-opiomelanocortin, cocaine-amphetamine-regulated transcript other drugs with similar action phentermine, sibutramine and bupropion (ref. 1) 2012 MFMER slide-24

25 Smoking and Diabetes Increased insulin resistance increase visceral fat. Adiponectin (adipose-derived protein) modulates insulin sensitivity and is lower in smokers. Smokers have increased risk of Diabetes, but smoking cessation leads to higher short-term risk. (ref.10) 2012 MFMER slide-25

26 Mechanism of weight gain with cessation Decreased metabolic rate Increased caloric intake Just the opposite effects of nicotine In one study average increase in caloric intake in exsmokers was 227 calories/day Nicotine s appetite suppressant effect --reversed upon quitting 2012 MFMER slide-26

27 2 nd mechanism of weight gain Smoking and overeating are both compulsory habits Substitute nicotine reward with food reward Eating becomes alternative to smoking Increased desire for comfort foods usually fats and sweets 2012 MFMER slide-27

28 Smoking cessation and gastric emptying In a Japanese study of 53 habitual smokers Smoking cessation temporarily accelerated gastric emptying which may lead to temporary increase in appetite resulting in weight gain (ref. 2) 2012 MFMER slide-28

29 Smoking to control weight Concept barrier to smoking cessation especially for women Even in 1930s, cigarette advertisements to women reach for a cigarette instead of a sweet 2012 MFMER slide-29

30 Weight gain concern A common and significant barrier to smoking cessation for many smokers resulting in smoking relapse (ref. 11) In a large population-based study, 52% of women and 32% of men reported weight gain was one of the reasons for relapse (Ref 5) 2012 MFMER slide-30

31 Weight gain concern Stronger predictor of relapse than actual weight gain 1. SCP + counseling to reduce concerns about weight gain 2. SCP + diet advice to prevent weight gain 3. one group of smokers-- standard smoking cessation counseling (SCP) 2012 MFMER slide-31

32 1 year follow up results 21% of weight concerns group abstinent weight gain 5.5 lbs. 13% of weight control abstinent weight gain 11.9 lbs. 9% of standard smoking cessation abstinent -- weight gain 16.9 lbs (ref 6) 2012 MFMER slide-32

33 Weight gain concerns In a similar more recent study with cognitive behavioral therapy (CBT) Bupropion +CBT for weight concerns had higher 6 month abstinence rates (34%) vs. Bup + standard counseling(21%) or CBT for weight concerns + placebo (11.5%) There was no difference among these groups in post cessation weight gain (ref. 7) 2012 MFMER slide-33

34 Adolescence smoking Smoking perceived as weight control method by adolescent girls. Not proven in this age group, but perception is real Tracks into adulthood Young adults trying to lose weight --40% more likely to smoke cigarettes 2012 MFMER slide-34

35 Smoking and weight concerns in adolescents Survey of 4,523 US high school students Heavy smokers most likely to consume unhealthy diet All smokers (light and heavy) more likely to engage in unhealthy dietary restrictions Dietary restrictions were related to smoking-related weight concerns (ref 8): 2012 MFMER slide-35

36 Medications to prevent weight gain Bupropion one of 7 FDA approved drugs for smoking cessation has been shown to attenuate food reward and suppress weight gain In a Cochrane Database review, Buproprion (300mg/day) was found to limit post cessation weight gain (-0.76 kg.) at the end of treatment. However after one year there was no effect. NRT limited weight gain post cessation (-0.45 kg.) No effect after one year There was no evidence that Varenicline reduced post cessation weight gain (Ref. 12) 2012 MFMER slide-36

37 Exercise In the Cochrane Data review, there was no evidence that exercise reduced post-cessation weight at the end of treatment BUT there was evidence for an effect at 12 months (-2.07 kg.) (95% CI kg 0.36 kg) (ref. 12) 2012 MFMER slide-37

38 Medications to prevent weight gain Standard smoking cessation pharmacotherapy with NRT, bupropion appear to delay rather than prevent post-cessation weight gain. Bupropion may be the most effective especially if combined with a program that includes counseling for weight gain concerns (ref. 1) 2012 MFMER slide-38

39 Rimonabant Effective treatment for both tobacco dependence and obesity. A cannabinoid receptor antagonist. Adverse psychiatric effects--not FDA approved 2012 MFMER slide-39

40 Tobacco company role in weight control A systematic search of the archives of 6 major US and UK tobacco companies Appetite- suppressant molecules such as tartaric acid and 2-acetylpyridein were added to some cigarettes. Tobacco industry played an active role in adding appetite-suppressants to cigarettes (ref 9) 2012 MFMER slide-40

41 Intervention/treatment Behavioral interventions to maintain energy balance Manage calorie intake Increase physical activity Deal with concerns about weight gain counseling group gained less weight than both standard therapy group and weight control group 2012 MFMER slide-41

42 Future treatments Topiramate (TPM) an anticonvulsant known to produce weight loss (6.5% vs. placebo at 6 months). Consider combined TPM with NRT Phentermine/TPM to be approved soon by FDA for treatment of obesity-could also be combined with standard smoking cessation pharmacotherapy 2012 MFMER slide-42

43 Summary --Cigarette smokers are more likely to have normal weights or body mass index (BMI) --Nicotine has been the most effective long-term weight control drug over the last century. --Unfortunately when it s delivered via cigarette smoke it is extremely toxic resulting in premature deaths of half of those who are lifelong smokers. (Ref. 1) 2012 MFMER slide-43

44 Summary --smoking cessation does result in a small but significant weight gain --Further studies need to be done to better understand the mechanism of weight gain and explore new treatment strategies --Weight gain concerns should be addressed in smoking cessation programs Future studies should consider combining established weight loss medications with standard smoking cessation pharmacotherapy 2012 MFMER slide-44

45 References 1. Cigarette Smoking, Nicotine, and Body Weight J. Audrain-McGovern and N. L Benowitz Clinical Pharmacology & Therapeutics (2011) 90, Published online June 1, 2011 (Pub Med) 2. Kadota K et al, J. Clin Gastroenterol. 2010, April; 44(4) 2012 MFMER slide-45

46 References 3. Brook DW, Zhang C et al; NTR 2010 March; 122 (3); EPIC/PANACEA study, Travier N, Prev Med, Sept 12, 2011) 5.Psinger C.. Prev. Med. April 2007;44(4):290-95) 6. Meyers AW, J. consult Clin. Psychol. 1997; 65:448) 7. Levine, Arch Intern Med, 2010 mar 22; 170(6): Cavallo Da et al; Pediatrics 2010 Jul.) 2012 MFMER slide-46

47 References 9. Eur J Public health 2011, April Yeh HC et al, Ann Intern Meds, 2010, Jan Borrelli B, Addict. Behav. 1998;23(5): Parsons AC, Cochrane Database Syst Rev. 2012;1:CD MFMER slide-47

ΑΡΑΠΟΓΙΑΝΝΗ ΑΘΗΝΑ Αναπληρώτρια Διευθύντρια Γ Καρδιολογικής Κλινικής Ευρωκλινικής Αθηνών

ΑΡΑΠΟΓΙΑΝΝΗ ΑΘΗΝΑ Αναπληρώτρια Διευθύντρια Γ Καρδιολογικής Κλινικής Ευρωκλινικής Αθηνών ΑΡΑΠΟΓΙΑΝΝΗ ΑΘΗΝΑ Αναπληρώτρια Διευθύντρια Γ Καρδιολογικής Κλινικής Ευρωκλινικής Αθηνών Δεν υπάρχει σύγκρουση συμφερόντων Mets and Cigarette Smoking Status Nicotine- one of the most heavily used addictive

More information

Heather Dacus, DO, MPH Preventive Medicine Physician Director, Bureau of Chronic Disease Control New York State Department of Health

Heather Dacus, DO, MPH Preventive Medicine Physician Director, Bureau of Chronic Disease Control New York State Department of Health Heather Dacus, DO, MPH Preventive Medicine Physician Director, Bureau of Chronic Disease Control New York State Department of Health Disclosure Heather Dacus has no real or perceived vested interests that

More information

Obesity D R. A I S H A H A L I E K H Z A I M Y

Obesity D R. A I S H A H A L I E K H Z A I M Y Obesity D R. A I S H A H A L I E K H Z A I M Y Objectives Definition Pathogenesis of obesity Factors predisposing to obesity Complications of obesity Assessment and screening of obesity Management of obesity

More information

Wanting to Get Pregnant

Wanting to Get Pregnant Continuing Medical Education COPD Case Presentation LEARNING OBJECTIVES Those completing this activity will receive information that should allow them to Assist a patient in developing a quit plan; Advise

More information

Update on Medications for Tobacco Cessation

Update on Medications for Tobacco Cessation Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction

More information

Varenicline and Other Pharmacotherapies for Tobacco Dependence

Varenicline and Other Pharmacotherapies for Tobacco Dependence Varenicline and Other Pharmacotherapies for Tobacco Dependence J. Taylor Hays, M.D. Associate Director Nicotine Dependence Center Mayo Clinic 2012 MFMER slide-1 Learning Objectives Understand the mechanism

More information

MEDICAL MANAGEMENT 101

MEDICAL MANAGEMENT 101 MEDICAL MANAGEMENT 101 Christopher Still, DO, FACN, FACP Medical Director, Center for Nutrition & Weight Management Director, Geisinger Obesity Research Institute Geisinger Health Care System Your Weight

More information

Physical activity as an aid for smoking cessation

Physical activity as an aid for smoking cessation Physical activity as an aid for smoking cessation - study David Faeh, MD Christiane Ruffieux, PhD Jacques Cornuz, MD, MPH Background Prevalence of smoking in Switzerland: 33% Most smokers cumulate both

More information

Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D.

Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D. Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D. Prevalence of Smoking and Cessation During Pregnancy In 2014, 14% in women with Medicaid coverage versus 3.6% of women with

More information

Effective Treatments for Tobacco Dependence

Effective Treatments for Tobacco Dependence Effective Treatments for Tobacco Dependence Abigail Halperin MD, MPH Director, University of Washington Tobacco Studies Program Ken Wassum Associate Director of Clinical Development and Support Quit for

More information

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Diabesity Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs Abdominal obesity Low HDL, high LDL, and high triglycerides HTN High blood glucose (F>100l,

More information

Tobacco Dependence Treatment From Neurobiology through Public Policy

Tobacco Dependence Treatment From Neurobiology through Public Policy Tobacco Dependence Treatment From Neurobiology through Public Policy Mary Ellen Wewers, PhD, MPH, RN Professor Emerita The Ohio State University College of Public Health Disclosures Funding from the National

More information

WEIGHT LOSS/MANAGEMENT IS IT JUST ANOTHER PIPE DREAM?

WEIGHT LOSS/MANAGEMENT IS IT JUST ANOTHER PIPE DREAM? WEIGHT LOSS/MANAGEMENT IS IT JUST ANOTHER PIPE DREAM? THE OBESITY MEDICINE ASSOCIATION S DEFINITION OF OBESITY Obesity is defined as a chronic, relapsing, multi-factorial, neurobehavioral disease, wherein

More information

Rimonabant for treating tobacco dependence

Rimonabant for treating tobacco dependence REVIEW Rimonabant for treating tobacco dependence Michael B Steinberg 1,2 Jonathan Foulds 1 1 University of Medicine and Dentistry of New Jersey School of Public Health, Tobacco Dependence Program, New

More information

The Quit Clinic As an Anti-smoking Advocacy Tool

The Quit Clinic As an Anti-smoking Advocacy Tool The Quit Clinic As an Anti-smoking Advocacy Tool Associate Professor Chanchai Sittipunt MD Division of Pulmonary and Critical Care Medicine Department of Internal Medicine Faculty of Medicine Chulalongkorn

More information

Background. Abstinence rates associated with varenicline

Background. Abstinence rates associated with varenicline What are the range of abstinence rates for varenicline for smoking cessation? Do they differ based on treatment duration? Are there any studies utilizing 3-4 months of varenicline treatment? Background

More information

Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions

Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions Jill M Williams, MD Professor Psychiatry Director, Division Addiction Psychiatry Robert Wood Johnson Medical School Disclosures

More information

Management of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications.

Management of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications. Medical Management of Obesity Ben O Donnell, MD 1 Objectives Background Impact and scope of Obesity Control of Energy Homeostasis Methods of treatment Medications 2 O'Donnell 1 Impact of Obesity According

More information

Management of Tobacco Dependence. Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur

Management of Tobacco Dependence. Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur Management of Tobacco Dependence Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur Difficult to identify any other condition that presents such a mix of lethality, prevalence,

More information

SMOKING CESSATION WORKSHOP. Dr Mark Palayew December

SMOKING CESSATION WORKSHOP. Dr Mark Palayew December SMOKING CESSATION WORKSHOP Dr Mark Palayew December 5 2016 Conflicts of Interest None Case 1 Mr. T is a 55 year old smoker 2 packs/day He has been smoking continuously since age 16 When he wakes up at

More information

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD Smoking Cessation A Clinicians Perspective Jeff Wilson, MD Overview Tobacco control what we have accomplished and the road ahead Role of the health care professional Using pharmacotherapy Electronic cigarettes

More information

PHARMACOTHERAPY OF SMOKING CESSATION

PHARMACOTHERAPY OF SMOKING CESSATION PHARMACOTHERAPY OF SMOKING CESSATION Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure

More information

Pharmacotherapy for Treating Tobacco Dependence

Pharmacotherapy for Treating Tobacco Dependence Pharmacotherapy for Treating Tobacco Dependence Sheila K. Stevens, MSW Education Coordinator Nicotine Dependence Center 2013 MFMER slide-1 Rationale for Pharmacological Therapy Success rate doubles Manage

More information

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO

EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO EVIDENCE-BASED INTERVENTIONS TO HELP PATIENTS QUIT TOBACCO Lena Matthias Gray, MSA, CTTS-M University of Michigan MHealthy Tobacco Consultation Service Overview of Tobacco Use The World Health Organization

More information

MYTH #1. Nicotine is a harmful, medically dangerous drug. Nicotine: Myths, Realities & Treatment OBJECTIVES FACT. CSAM Board Review Course, 10/23/08

MYTH #1. Nicotine is a harmful, medically dangerous drug. Nicotine: Myths, Realities & Treatment OBJECTIVES FACT. CSAM Board Review Course, 10/23/08 Nicotine: Myths, Realities & Treatment CSAM Board Review Course, Newport Beach, CA Presented by David P.L. Sachs, MD Director, Palo Alto Center for Pulmonary Disease Prevention & Clinical Associate Professor,

More information

BASIC SKILLS FOR WORKING WITH SMOKERS

BASIC SKILLS FOR WORKING WITH SMOKERS BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 368 Plantation Street, Worcester, MA 01605 www.umassmed.edu/tobacco 2018 Basic Skills for Working with Smokers 1 Table

More information

Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence

Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence Nancy Rigotti, MD Tobacco Research & Treatment Center, General Medicine Division, Massachusetts General Hospital, Harvard

More information

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD

Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes. Stephen D. Sisson MD Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes

More information

An Evolving Perspective on Smoking Cessation Therapies

An Evolving Perspective on Smoking Cessation Therapies An Evolving Perspective on Smoking Cessation Therapies Andrew Pipe, CM, MD Chief, Division of Prevention & Rehabilitation University of Ottawa Heart Institute Faculty/Presenter Disclosure Andrew Pipe,

More information

Tobacco & Nicotine: Addiction and Treatment

Tobacco & Nicotine: Addiction and Treatment Tobacco & Nicotine: Addiction and Treatment Tim McAfee, MD, MPH Chief Medical Officer - Free & Clear 206-876-2551 - tim.mcafee@freeclear.com Affiliate Assistant Professor, University of Washington, School

More information

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives.

Part 1: Obesity. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes 10/15/2018. Objectives. Dietary recommendations in Obesity, Hypertension, Hyperlipidemia, and Diabetes Stephen D. Sisson MD Objectives To review dietary recommendations in the following conditions: Obesity Hypertension Diabetes

More information

BASIC SKILLS FOR WORKING WITH SMOKERS

BASIC SKILLS FOR WORKING WITH SMOKERS BASIC SKILLS FOR WORKING WITH SMOKERS Course Description Goals and Learning Objectives 55 Lave Ave No, Worcester, MA 01655 www.umassmed.edu/tobacco 2016 Basic Skills for Working with Smokers 1 Table of

More information

Brief Intervention for Smoking Cessation. National Training Programme

Brief Intervention for Smoking Cessation. National Training Programme Brief Intervention for Smoking Cessation National Training Programme Introduction Monitor tobacco use and prevention policies Protect people from tobacco smoke Offer help to quit tobacco use Warn about

More information

Treatment of Obesity SAJIDA AHAD MERCY GENERAL SURGERY

Treatment of Obesity SAJIDA AHAD MERCY GENERAL SURGERY Treatment of Obesity SAJIDA AHAD MERCY GENERAL SURGERY Objectives 1. Learn classification and evaluation of overweight and obese patient 2. Discuss impact of voluntary weight loss on morbidity and mortality

More information

Tobacco dependence: Implications for service provision

Tobacco dependence: Implications for service provision Tobacco dependence: Implications for service provision Andy McEwen, PhD University College London & National Centre for Smoking Cessation and Training (NCSCT) Tuesday 29th January 2013 Cardiff Conflict

More information

Interdisciplinary Certification in Obesity and Weight Management Detailed Content Outline

Interdisciplinary Certification in Obesity and Weight Management Detailed Content Outline 1. Patient Assessment and Development of Treatment Plan (35 Items) A. Patient History and Current Status 1. Collect patient assessment information: a. weight history, including development genetics growth

More information

Developing nations vs. developed nations Availability of food contributes to overweight and obesity

Developing nations vs. developed nations Availability of food contributes to overweight and obesity KNH 406 1 Developing nations vs. developed nations Availability of food contributes to overweight and obesity Intake Measured in kilojoules (kj) or kilocalories (kcal) - food energy Determined by bomb

More information

Smoking Status and Body Mass Index in the United States:

Smoking Status and Body Mass Index in the United States: Smoking Status and Body Mass Index in the United States: 1996-2000 Jun Yang, MD, PhD and Gary Giovino, PhD Roswell Park Cancer Institute Elm and Carlton Streets Buffalo, NY 14263, USA Society for Research

More information

by Marilyn Williams Nutrition & Weight Management Consultant

by Marilyn Williams Nutrition & Weight Management Consultant by Marilyn Williams Nutrition & Weight Management Consultant Copyright 2018 Marilyn Williams All Rights Reserved This work is Copyright and not to be copied or shared in any fashion. Disclaimer: The information,

More information

Setting the Stage: Tobacco s Impact on Smokers, Employers, and Florida

Setting the Stage: Tobacco s Impact on Smokers, Employers, and Florida Setting the Stage: Tobacco s Impact on Smokers, Employers, and Florida Thomas H. Brandon, Ph.D. H. Lee Moffitt Cancer Center & Research Institute Florida Tobacco Cessation Summit October 14, 2010 Moffitt

More information

THE STATE OF MEDICINE IN ADDICTION RECOVERY

THE STATE OF MEDICINE IN ADDICTION RECOVERY OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,

More information

EMERGING ISSUES IN SMOKING CESSATION

EMERGING ISSUES IN SMOKING CESSATION EMERGING ISSUES IN SMOKING CESSATION Andrew Pipe, CM, MD Chief, Division of Prevention & Rehabilitation University of Ottawa Heart Institute Faculty/Presenter Disclosure Andrew Pipe, CM, MD University

More information

Next Lipitor will also be from metabolic therapy

Next Lipitor will also be from metabolic therapy 8 Review Article Next Lipitor will also be from metabolic therapy Amit Gangwal Department of pharmacognosy Smriti college of pharmaceutical education, Indore gangwal.amit@gmail.com Because such is the

More information

Pharmacologic Therapy for Tobacco Use & Dependence

Pharmacologic Therapy for Tobacco Use & Dependence Pharmacologic Therapy for Tobacco Use & Dependence Thomas Gauvin, MA, TTS Mayo Clinic Nicotine Dependence Center Rochester, MN 2013 MFMER slide-1 Learning Objectives Understand the 7 first line medications

More information

Tobacco Use in Adolescents

Tobacco Use in Adolescents Tobacco Use in Adolescents Joycelyn Lawrence, MD Leonard Miller School of Medicine at the University of Miami Department of Family Medicine 1 Overview Description: This section will introduce you to the

More information

OBESITY IN PRIMARY CARE

OBESITY IN PRIMARY CARE OBESITY IN PRIMARY CARE Obesity- definition Is a chronic disease In ICD 10 E66 Overweight and obesity are defined as abnormal or excessive fat accumulation that may impair health. Obesity is a leading

More information

If treatment for tobacco addiction was evidence-based, what would it look like? Robert West University College London YORK, November 2005

If treatment for tobacco addiction was evidence-based, what would it look like? Robert West University College London YORK, November 2005 If treatment for tobacco addiction was evidence-based, what would it look like? Robert West University College London YORK, November 2005 Outline What is tobacco addiction and what is the goal of treatment?

More information

Tobacco Use Dependence and Approaches to Treatment

Tobacco Use Dependence and Approaches to Treatment University of Kentucky UKnowledge Nursing Presentations College of Nursing 11-2011 Tobacco Use Dependence and Approaches to Treatment Audrey Darville University of Kentucky, audrey.darville@uky.edu Chizimuzo

More information

NICOTINE PHARMACOLOGY and PRINCIPLES of ADDICTION. 3 rd of 3 Prep for Session 1

NICOTINE PHARMACOLOGY and PRINCIPLES of ADDICTION. 3 rd of 3 Prep for Session 1 NICOTINE PHARMACOLOGY and PRINCIPLES of ADDICTION 3 rd of 3 Prep for Session 1 CHEMISTRY of NICOTINE Pyridine ring N H N CH 3 Pyrrolidine ring Nicotiana tabacum Natural liquid alkaloid Colorless, volatile

More information

The 5A's are practice guidelines on tobacco use prevention and cessation treatment (4):

The 5A's are practice guidelines on tobacco use prevention and cessation treatment (4): Smoking Cessation Module Tobacco use is the single greatest preventable cause of chronic diseases and premature deaths worldwide. The Canadian Cancer Society reports that tobacco product use is responsible

More information

Chapter 1 Making Personal Wellness Choices

Chapter 1 Making Personal Wellness Choices Chapter 1 Making Personal Wellness Choices 1.1 Multiple Choice 1) Wellness is defined as A) the absence of disease. B) the highest level of fitness. C) the optimal soundness of body and mind. D) the ability

More information

Smokeless Tobacco Cessation: Review of the evidence. Raymond Boyle, PhD Tobacco Summit 2007 MDQuit.org

Smokeless Tobacco Cessation: Review of the evidence. Raymond Boyle, PhD Tobacco Summit 2007 MDQuit.org Smokeless Tobacco Cessation: Review of the evidence Raymond Boyle, PhD Tobacco Summit 2007 MDQuit.org Previous Reviews of ST evidence Hatsukami and Boyle (1997) Evidence base is limited by small sample

More information

TO ONE S SELF, OTHERS,& ENVIRONMENT

TO ONE S SELF, OTHERS,& ENVIRONMENT SMOKING IS A HEALTH DESTRUCTIVE HABIT TO ONE S SELF, OTHERS,& ENVIRONMENT EVERY SMOKER SHOULD BE OFFERED TREATMENT TO QUIT Juliette Jibrail Juliette Jibrail Nov. 11, 2007 Thorough Internet Search Variety

More information

Project ECHO Importance of Treating Tobacco Use In People With Behavioral Health Disorders Jan Blalock, Ph.D.

Project ECHO Importance of Treating Tobacco Use In People With Behavioral Health Disorders Jan Blalock, Ph.D. Project ECHO Importance of Treating Tobacco Use In People With Behavioral Health Disorders Jan Blalock, Ph.D. High Levels Of Tobacco Use Almost twice as likely to smoke as people without disorders (36.1%

More information

Pharmacological interventions for smoking cessation: an overview and network meta-analysis (Review)

Pharmacological interventions for smoking cessation: an overview and network meta-analysis (Review) Pharmacological interventions for smoking cessation: an overview and network meta-analysis (Review) Cahill K, Stevens S, Perera R, Lancaster T This is a reprint of a Cochrane review, prepared and maintained

More information

UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING

UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING Course Description Goals and Learning Objectives 55 Lake Ave North, Worcester, MA 01655 www.umassmed.edu/tobacco 1 Table of Contents Determinants of Nicotine

More information

Smoking Cessation. Disclosures. Thank You. None

Smoking Cessation. Disclosures. Thank You. None Smoking Cessation Dr. Jamie Kellar; BSc, BScPhm, PharmD Clinician Educator Centre for Addiction and Mental Health Assistant Professor Leslie Dan Faculty of Pharmacy Disclosures None Thank You Several slides

More information

Keywords: tobacco, cigarette smoke, nicotine, dopamine, smoking cessation, acethylcholine, varenicline (champix )

Keywords: tobacco, cigarette smoke, nicotine, dopamine, smoking cessation, acethylcholine, varenicline (champix ) Review Article and Clinical Experience: ENICLINE (CHAMPIX ) : A BREAKTHROUGH FOR SMOKING CESSATION TREATMENT (An α4ß2 Nicotinic Acethylcholine Receptor Partial Agonist) Askandar Tjokroprawiro Diabetes

More information

Cigarettes and Other Nicotine Products

Cigarettes and Other Nicotine Products Cigarettes and Other Nicotine Products Nicotine is one of the most heavily used addictive drugs in the United States. In 2002, 30 percent of the U.S. population 12 and older 71.5 million people used tobacco

More information

Primary Care Smoking Cessation. GP and Clinical Director WRPHO Primary Care Advisor MOH Tobacco Team Target Champion Primary Care Tobacco

Primary Care Smoking Cessation. GP and Clinical Director WRPHO Primary Care Advisor MOH Tobacco Team Target Champion Primary Care Tobacco Primary Care Smoking Cessation Dr John McMenamin GP and Clinical Director WRPHO Primary Care Advisor MOH Tobacco Team Target Champion Primary Care Tobacco Target or Tickbox? The Tobacco health target:

More information

Smoking Cessation: Good News at Last!

Smoking Cessation: Good News at Last! Smoking Cessation: Good News at Last! Andrew L. Pipe, CM, MD The Minto Prevention & Rehabilitation Centre University of Ottawa Heart Institute Ottawa, Ontario. Canada apipe@ottawaheart.ca Declaration of

More information

Smoking Cessation. Samer Kanaan, M.D.

Smoking Cessation. Samer Kanaan, M.D. Smoking Cessation Samer Kanaan, M.D. Goals Understand the Societal impact of Smoking Smoking Cessation: The 5 A Model - Ask, Advise, Assess, Assist, Arrange Review The Stages of Change Review smoking cessation

More information

Michael G. Knight, MD, MSHP, Dipl. ABOM Assistant Professor of Medicine The George Washington University

Michael G. Knight, MD, MSHP, Dipl. ABOM Assistant Professor of Medicine The George Washington University Michael G. Knight, MD, MSHP, Dipl. ABOM Assistant Professor of Medicine The George Washington University Disclosures I have no actual or potential conflict of interest in relation to this presentation

More information

Tobacco Use and Reproductive Health: An Update

Tobacco Use and Reproductive Health: An Update Project with Alberta Health Services Christene Fetterly Gail Foreman and Tasha Allen Tobacco Use and Reproductive Health: An Update Lorraine Greaves PhD Nancy Poole PhD Natalie Hemsing, Research Associate,

More information

Professional Diploma. in Nutrition. Module 1. Lesson 1: Health is Your Wealth EQF Level 5. Professional Diploma

Professional Diploma. in Nutrition. Module 1. Lesson 1: Health is Your Wealth EQF Level 5. Professional Diploma Professional Diploma in Nutrition Module 1 Lesson 1: Health is Your Wealth EQF Level 5 Professional Diploma What is Anthropometry? External measurement of body composition Tells you how much of your weight

More information

Breaking the Chains of Nicotine Dependence - A Breakthrough Approach

Breaking the Chains of Nicotine Dependence - A Breakthrough Approach Breaking the Chains of Nicotine Dependence - A Breakthrough Approach Dr Rob Young Senior Lecturer & Consultant Physician Auckland Hospital, New Zealand Smoking Cessation in 2001 Smoking contributes to

More information

TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS

TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS Fact Sheet N 127 August 1996 TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS Psychoactive substance use is an increasing public health concern. Problems associated with this use cover a broad spectrum

More information

TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS

TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS Learning Objectives TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS Cheyenne Newsome, PharmD PGY2 Ambulatory Care Resident University of New Mexico College of

More information

Electronic Cigarettes, Nicotine and Policy Implications

Electronic Cigarettes, Nicotine and Policy Implications Electronic Cigarettes, Nicotine and Policy Implications Neal L Benowitz MD University of California San Francisco The E-Cigarette Summit The Royal Society London November 17, 2016 Disclosures Dr Benowitz

More information

UGRC 145: FOOD AND NUTRITION IN EVERYDAY LIFE

UGRC 145: FOOD AND NUTRITION IN EVERYDAY LIFE UGRC 145: FOOD AND NUTRITION IN EVERYDAY LIFE Session 9 ENERGY BALANCE Lecturer: PROF. MATILDA STEINER-ASIEDU, SBS, CBAS; University of Ghana, Email: tillysteiner@gmail.com College of Education School

More information

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI

More information

When Diet and Exercise Aren t Enough: Pharmacologic Management of Obesity

When Diet and Exercise Aren t Enough: Pharmacologic Management of Obesity When Diet and Exercise Aren t Enough: Pharmacologic Management of Obesity Casey Bonaquist, DO Saturday, April 30 th, 2016 17 th Annual Primary Care & Cardiovascular Symposium Learning Objectives After

More information

TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS

TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS TOBACCO CESSATION: INCORPORATING MOTIVATIONAL INTERVIEWING AND EXAMINING THE ROLE OF E-CIGS Cheyenne Newsome, PharmD PGY2 Ambulatory Care Resident University of New Mexico College of Pharmacy Learning

More information

Smoking Cessation: Where Are We Now? Nancy Rigotti, MD

Smoking Cessation: Where Are We Now? Nancy Rigotti, MD Smoking Cessation: Where Are We Now? Nancy Rigotti, MD Director, MGH Tobacco Research and Treatment Center Professor of Medicine, Harvard Medical School nrigotti@partners.org OVERVIEW The challenge for

More information

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation

More information

Helping People Quit Tobacco

Helping People Quit Tobacco Helping People Quit Tobacco Peter Selby MBBS, CCFP, MHSc, ASAM Associate Professor, University of Toronto Clinical Director, Addictions Program, CAMH Principal Investigator, OTRU Disclosures! Grants/research

More information

The Implications of Obesity as a Disease

The Implications of Obesity as a Disease AGA Technology Workshop The Implications of Obesity as a Disease Lee M. Kaplan, MD, PhD Obesity, Metabolism & Nutrition Institute Massachusetts General Hospital Harvard Medical School LMKaplan@partners.org

More information

Over the Road Truck Driver Who Smokes

Over the Road Truck Driver Who Smokes Continuing Medical Education Case Presentation 1 CME Credit Physicians Physician Assistants Nurse Practitioners Over the Road Truck Driver Who Smokes RELEASE & REVIEW DATE This activity was last reviewed

More information

Smoking Cessation Strategies in 2017

Smoking Cessation Strategies in 2017 Smoking Cessation Strategies in 2017 Robert Schilz DO, PhD, FCCP Division of Pulmonary, Critical Care and Sleep Medicine Director of Lug Transplantation University Hospitals of Cleveland Case Western University

More information

OBESITY:Pharmacotherapy Vs Surgery

OBESITY:Pharmacotherapy Vs Surgery OBESITY:Pharmacotherapy Vs Surgery Dr. Ranajit Sen Chowdhury Associate Professor Department of Medicine Sir Salimullah Medical College & Mitford Hospital. 1 Historical Perspective Paleolithic Era > 25,000

More information

Finding what works for weight in the workplace

Finding what works for weight in the workplace Finding what works for weight in the workplace Existing data and future directions Andrew Brown, PhD 2019-02-08 Acknowledgments Some slides were inspired by or made in collaboration with numerous colleagues.

More information

Understanding the Impact of Cigarette Smoking Using Brain Imaging

Understanding the Impact of Cigarette Smoking Using Brain Imaging Understanding the Impact of Cigarette Smoking Using Brain Imaging Angelica Morales, PhD Postdoctoral Fellow Developmental Brain Imaging Lab Oregon Health & Science University No Financial Disclosures The

More information

Obesity in Children. JC Opperman

Obesity in Children. JC Opperman Obesity in Children JC Opperman Definition The child too heavy for height or length Obvious on inspection 10 to 20% over desirable weight = overweight More than 20% = obese Use percentile charts for the

More information

Definition High Blood Pressure is a

Definition High Blood Pressure is a May 10th 2014 Definition High Blood Pressure is a common condition in which the force of the blood against your artery walls is high enough that it may eventually cause health problems, such as heart disease.

More information

Motivating Smoking Cessation: Recognizing and Capitalizing on Teachable Moments

Motivating Smoking Cessation: Recognizing and Capitalizing on Teachable Moments Motivating Smoking Cessation: Recognizing and Capitalizing on Teachable Moments Belinda Borrelli, PhD Professor & Director, The Miriam Hospital and Brown Medical School, Program in Nicotine and Tobacco

More information

Evidence-based Practice

Evidence-based Practice Evidence-based Practice Michael V. Burke, EdD Assistant Professor of Medicine Treatment Program Coordinator Mayo Clinic Nicotine Dependence Center May, 2013 Learning objectives At the end of this presentation

More information

ADHD & Addictions -What We Know

ADHD & Addictions -What We Know ADHD & Addictions -What We Know Dr. David Teplin, Psy.D., C.Psych. 4th CADDAC Annual Conference, Toronto October 14, 2012 1 Introduction Adult ADHD commonly co-exists with several other disorders, including

More information

EFFECT OF SMOKING ON BODY MASS INDEX: A COMMUNITY-BASED STUDY

EFFECT OF SMOKING ON BODY MASS INDEX: A COMMUNITY-BASED STUDY ORIGINAL ARTICLE. EFFECT OF SMOKING ON BODY MASS INDEX: A COMMUNITY-BASED STUDY Pragti Chhabra 1, Sunil K Chhabra 2 1 Professor, Department of Community Medicine, University College of Medical Sciences,

More information

Special Populations: Guidelines for Pregnant Smokers

Special Populations: Guidelines for Pregnant Smokers Special Populations: Guidelines for Pregnant Smokers Jennifer S. B. Moran, MA Mayo Clinic Best Practice Brief cessation counseling 5-15 minutes by a trained health care provider, combined with pregnancyspecific

More information

Best Practice for Smoking Cessation: Pharmacotherapy. Emma Dean Acting Population Health and Health Promotion Coordinator Lead Pharmacist- Smokefree

Best Practice for Smoking Cessation: Pharmacotherapy. Emma Dean Acting Population Health and Health Promotion Coordinator Lead Pharmacist- Smokefree Best Practice for Smoking Cessation: Pharmacotherapy Emma Dean Acting Population Health and Health Promotion Coordinator Lead Pharmacist- Smokefree Why is it so hard to quit? People who smoke aren t weak

More information

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018 Smoking Cessation in Pregnancy Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018 Tobacco Cessation in Pregnancy: Objective 1. Overview of the negative effects of tobacco abuse in

More information

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.

Effective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D. Effective Interventions in the Clinical Setting: Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. UNIVERSITY OF NEVADA SCHOOL of MEDICINE Sept. 8, 2011 Reality check: What could

More information

PSK409-Health Psychology

PSK409-Health Psychology PSK409-Health Psychology An Introduction to Health Psychology Val Morrison and Paul Bennett Chapter 3 Health Risk Behavior Assoc. Prof. Okan Cem Çırakoğlu okanc@baskent.edu.tr Learning Outcomes By the

More information

Managing Obesity AS A CHRONIC DISEASE by Nadia B. Pietrzykowska, MD, FACP

Managing Obesity AS A CHRONIC DISEASE by Nadia B. Pietrzykowska, MD, FACP Managing Obesity AS A CHRONIC DISEASE by Nadia B. Pietrzykowska, MD, FACP What Makes Obesity a Disease? What Makes Obesity a Chronic Disease? Obesity was officially classified as a disease by the American

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.

More information

3. Chantix [package insert]. New York, NY: Pfizer, Inc,; Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine

3. Chantix [package insert]. New York, NY: Pfizer, Inc,; Ramon JM, Morchon S, Baena A, Masuet-Aumatell C. Combining varenicline and nicotine How can there be a warning regarding concomitant use of varenicline with nicotine replacement therapy yet patients can be on varenicline and smoke concurrently? April 20, 2017 The United States (US) Preventive

More information

International Journal of Pharma and Bio Sciences COMPARISON OF EFFICACY AND SAFETY OF RIMONABANT WITH ORLISTAT IN OBESE AND OVERWEIGHT PATIENTS

International Journal of Pharma and Bio Sciences COMPARISON OF EFFICACY AND SAFETY OF RIMONABANT WITH ORLISTAT IN OBESE AND OVERWEIGHT PATIENTS International Journal of Pharma and Bio Sciences RESEARCH ARTICLE PHARMACOLOGY COMPARISON OF EFFICACY AND SAFETY OF RIMONABANT WITH ORLISTAT IN OBESE AND OVERWEIGHT PATIENTS Corresponding Author DR.JAIN

More information

How to help your patient quit smoking. Christopher M. Johnson MD, PhD

How to help your patient quit smoking. Christopher M. Johnson MD, PhD How to help your patient quit smoking Christopher M. Johnson MD, PhD Outline Smoking and its effects on IBD CD UC Clinical interventions Pharmacotherapy Resources Outline Smoking and its effects on IBD

More information

Tobacco treatment for people with serious mental illness (SMI)

Tobacco treatment for people with serious mental illness (SMI) Tobacco treatment for people with serious mental illness (SMI) An opportunity to close the mortality gap Massachusetts Mental Health Center 1 National Resource Center for Academic Detailing A compelling

More information

Trends in electronic cigarette use in England

Trends in electronic cigarette use in England Trends in electronic cigarette use in England Robert West Jamie Brown Emma Beard University College London Updated 14 th April 215 Background Electronic cigarette use has become prevalent in many countries

More information